Northwestern Medicine scientists have discovered a protein that acts as an entry point for the Epstein-Barr virus, providing a potential target for future therapies.
Northwestern Medicine scientists showed how enzyme inhibitors might be used to halt a molecular process that can cause neurodegeneration in patients with HIV.
A newly-designed mutant herpes virus provides a strategy for the development of novel herpes virus vaccines.
Research published in Proceedings of the National Academy of Sciences provides new insights into antibodies that block the Epstein-Barr virus from infecting human cells.
A Northwestern Medicine study found the human immunodeficiency virus uses proteins called diaphanous-related formins to hijack the cytoskeleton of healthy cells.
Northwestern Medicine scientists have developed technology that uses genomics and data analytics to efficiently screen for molecules produced by molds to find new drug prospects.
Northwestern Medicine scientists studied a poxvirus and demonstrated that ribosomes can selectively control the process of protein synthesis known as translation.
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
Northwestern Medicine scientists have discovered that the cholera strain responsible for the 2010 epidemic in Haiti is a hypervirulent variant.
Northwestern Medicine scientists discovered a crucial element underlying how proteins on the surface of enveloped viruses such as measles and mumps undergo a process that allows the virus to enter host cells.